CD44 and cancer: In various two- and three-dimensional (2D and 3D) culture models, CUR decreased the activity of cancer stem cells by inhibiting tumor cell proliferation, downregulating cancer stem-cell markers (i.e., CD44 and Oct4 [octamer-binding transcription factor 4]), and inducing apoptosis [37,38,39].